2018 심방세동 카테터 절제술 대한민국 진료지침: Part I = 2018 Korean Guidelines for Catheter Ablation of Atrial Fibrillation: Part I

다국어 초록 (Multilingual Abstract)

Catheter and surgical ablation of atrial fibrillation (AF) have evolved from investigational procedures to their current role as effective treatment options for patients with AF. Surgical ablation of AF is available in most major hospitals throughout the world. Catheter ablation of AF is even more widely available, and is now the most commonly performed catheter ablation procedure. Management of patients with AF has traditionally consisted of three main components: (1) anticoagulation for stroke prevention; (2) rate control; and (3) rhythm control. With the emergence of large amounts of data, which have both defined and called attention to the interaction between modifiable risk factors and the development of AF and outcomes of AF management, we believe it is time to include risk factor modification as the fourth pillar of AF management. Catheter and surgical ablation of AF are highly complex procedures, therefore a decision to perform catheter or surgical AF ablation should only be made after a patient carefully considers the risks, benefits, and alternatives to the procedure.

참고문헌 (Reference)

• 1 Chugh SS, "Worldwide epidemiology of atrial fibrillation : a Global Burden of Disease 2010 Study" 129 : 837-847, 2014
• 2 McCarthy PM, "Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation" 139 : 860-867, 2010
• 3 Kato T, "What are arrhythmogenic substrates in diabetic rat atria" 17 : 890-894, 2006
• 4 Winfree AT, "Vortex Action Potentials in Normal Ventricular Musclea" 591 : 190-207, 1990
• 5 Wolf RK, "Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation" 130 : 797-802, 2005
• 6 Gaita F, "Very Long-Term Results of Surgical and Transcatheter Ablation of Long-Standing Persistent Atrial Fibrillation" 96 : 1273-1278, 2013
• 7 Winfree AT, "Varieties of spiral wave behavior : An experimentalist’s approach to the theory of excitable media" 1 : 303-334, 1991
• 8 Benjamin EJ, "Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry" 41 : 879-, 2009
• 9 Gudbjartsson DF, "Variants conferring risk of atrial fibrillation on chromosome 4q25" 448 : 353-, 2007
• 10 Grundvold I, "Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men : a 35-year follow-up study" 59 : 198-204, 2012
• 11 Siontis KC, "Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community : Characteristics and prognostic implications" 13 : 1418-1424, 2016
• 12 Huxley RR, "Type 2 diabetes, glucose homeostasis and incident atrial fibrillation : the Atherosclerosis Risk in Communities study" 98 : 133-138, 2012
• 13 Tada H, "Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke" 45 : 2856-2862, 2014
• 14 Patterson E, "Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation" 2 : 624-631, 2005
• 15 Fein AS, "Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation" 62 : 300-305, 2013
• 16 Calkins H, "Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation : two systematic literature reviews and meta-analyses" 2 : 349-361, 2009
• 17 Calkins H, "Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency AblationCLINICAL PERSPECTIVE : Two Systematic Literature Reviews and Meta-Analyses" 2 : 349-361, 2009
• 18 Ben Amar M, "Towards a unified approach in the modeling of fibrosis : A review with research perspectives" 17 : 61-85, 2016
• 19 Edgerton JR, "Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the “Dallas” lesion set" 6 : S64-S70, 2009
• 20 Verheule S, "Tissue structure and connexin expression of canine pulmonary veins" 55 : 727-738, 2002
• 21 Gaztañaga L, "Time to recurrence of atrial fibrillation influences outcome following catheter ablation" 10 : 2-9, 2013
• 22 de Bakker JMT, "Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation" 2 : 777-779, 2005
• 23 Andrade J, "The time course of exit and entrance block during cryoballoon pulmonary vein isolation" 16 : 500-504, 2014
• 24 Inada K, "The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses : outcome during a 5-year follow-up" 16 : 208-213, 2014
• 25 Nalliah CJ, "The role of obesity in atrial fibrillation" 37 : 1565-1572, 2016
• 26 Gittenberger-de Groot AC, "The role of neural crest and epicardium-derived cells in conduction system formation" 250 : 125-134, 2003
• 27 Ghias M, "The role of ganglionated plexi in apnea-related atrial fibrillation" 54 : 2075-2083, 2009
• 28 Veasey RA, "The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease" 44 : 23-30, 2015
• 29 Krahn AD, "The natural history of atrial fibrillation : incidence, risk factors, and prognosis in the Manitoba Follow-Up Study" 98 : 476-484, 1995
• 30 Nattel S, "The multidimensional role of calcium in atrial fibrillation pathophysiology : mechanistic insights and therapeutic opportunities" 33 : 1870-1877, 2012
• 31 Wiener N, "The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle" 16 : 205-265, 1946
• 32 Tedrow UB, "The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS(women's health study)" 55 : 2319-2327, 2010
• 33 Kim DT, "The ligament of Marshall : a structural analysis in human hearts with implications for atrial arrhythmias" 36 : 1324-1327, 2000
• 34 Nathan H, "The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts" 34 : 412-422, 1966
• 35 Patel D, "The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females" 12 : 322-330, 2010
• 36 Letsas KP, "The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation" 164 : 94-98, 2013
• 37 Ganesan AN, "The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding : a systematic review and meta-analysis" 37 : 1591-1602, 2016
• 38 Al Chekakie MO, "The effects of statins and reninangiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation" 18 : 942-946, 2007
• 39 Kasapis C, "The effects of physical activity on serum C-reactive protein and inflammatory markers : a systematic review" 45 : 1563-1569, 2005
• 40 Sugihara C, "The development of AF over time in patients with permanent pacemakers : objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF" 17 : 864-870, 2015
• 41 Andrade J, "The clinical profile and pathophysiology of atrial fibrillation : relationships among clinical features, epidemiolog y, and mechanisms" 114 : 1453-1468, 2014
• 42 Kawashima T, "The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution" 209 : 425-438, 2005
• 43 Cabrera JA, "The architecture of the left lateral atrial wall : a particular anatomic region with implications for ablation of atrial fibrillation" 29 : 356-362, 2008
• 44 Kottkamp H, "The Substrate in"Early Persistent"Atrial Fibrillation : Arrhythmia Induced, Risk Factor Induced, or From a Specific Fibrotic Atrial Cardiomyopathy?" 2 : 140-142, 2016
• 45 Rankin JS, "The Society of Thoracic Surgeons Risk Model for Operative Mortality After Multiple Valve Surgery" 95 : 1484-1490, 2013
• 46 Badhwar V, "The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score : A Report of The Society of Thoracic Surgeons Quality Measurement Task Force" 101 : 2265-2271, 2016
• 47 Themistoclakis S, "The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation" 55 : 735-743, 2010
• 48 Garrey WE, "The Nature of Fibrillary Contraction of the Heart.-Its Relation to Tissue Mass and Form" 33 : 397-414, 1914
• 49 Kopecky SL, "The Natural History of Lone Atrial Fibrillation" 317 : 669-674, 1987
• 50 Pathak RK, "The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management" 31 : 203-210, 2015
• 51 Bunch TJ, "The Impact of Age on 5‐Year Outcomes After Atrial Fibrillation Catheter Ablation" 27 : 141-146, 2016
• 52 Hsieh MH, "The Different Mechanisms Between Late and Very Late Recurrences of Atrial Fibrillation in Patients Undergoing a Repeated Catheter Ablation" 17 : 231-235, 2006
• 53 Wang TJ, "Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality : the Framingham Heart Study" 107 : 2920-2925, 2003
• 54 Pinho-Gomes AC, "Targeting Inflammation and Oxidative Stress in Atrial Fibrillation : Role of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibition with Statins" 20 : 1268-1285, 2014
• 55 Greiser M, "Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes" 124 : 4759-4772, 2014
• 56 Schiller M, "TGF-β-induced SMAD signaling and gene regulation : consequences for extracellular matrix remodeling and wound healing" 35 : 83-92, 2004
• 57 Fjeldsoe B, "Systematic review of maintenance of behavior change following physical activity and dietary interventions" 30 : 99-109, 2011
• 58 Vasamreddy CR, "Symptomatic and Asymptomatic Atrial Fibrillation in Patients Undergoing Radiofrequency Catheter Ablation" 17 : 134-139, 2006
• 59 Davidenko JM, "Sustained vortex-like waves in normal isolated ventricular muscle" 87 : 8785-8789, 1990
• 60 Khargi K, "Surgical treatment of atrial fibrillation; a systematic review" 27 : 258-265, 2005
• 61 Ad N, "Surgical ablation of atrial fibrillation trends and outcomes in North America" 144 : 1051-1060, 2012
• 62 Kim HJ, "Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery" 102 : 1206-1214, 2016
• 63 Phan K, "Surgical ablation for treatment of atrial fibrillation in cardiac surgery : a cumulative meta-analysis of randomised controlled trials" 100 : 722-730, 2014
• 64 Barnett SD, "Surgical ablation as treatment for the elimination of atrial fibrillation : A meta-analysis" 131 : 1029-1035, 2006
• 65 Gillinov AM, "Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery" 372 : 1399-1409, 2015
• 66 Lin Y-J, "Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher" 15 : 676-684, 2013
• 67 Bunch TJ, "Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy" 19 : 1009-1014, 2008
• 68 Bian W, "Structure-related initiation of reentry by rapid pacing in monolayers of cardiac cells" 98 : e29-e38, 2006
• 69 Platonov PG, "Structural Abnormalities in Atrial Walls Are Associated With Presence and Persistency of Atrial Fibrillation But Not With Age" 58 : 2225-2232, 2011
• 70 Haïssaguerre M, "Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins" 339 : 659-666, 1998
• 71 Sanders P, "Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans" 112 : 789-797, 2005
• 72 de Bakker JM, "Slow conduction in the infarcted human heart. 'Zigzag' course of activation" 88 : 915-926, 1993
• 73 Bitter T, "Sleep-Disordered Breathing and Cardiac Arrhythmias" 31 : 928-934, 2015
• 74 Ling LH, "Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation" 10 : 1334-1339, 2013
• 75 Roberts-Thomson KC, "Sinus Node Disease : An Idiopathic Right Atrial Myopathy" 17 : 211-214, 2007
• 76 Lee S, "Simultaneous Biatrial High-Density(510-512Electrodes)Epicardial Mapping of Persistent and Long-Standing Persistent Atrial Fibrillation in Patients : New Insights Into the Mechanism of Its Maintenance" 132 : 2108-2117, 2015
• 77 Pokushalov E, "Selective ganglionated plexi ablation for paroxysmal atrial fibrillation" 6 : 1257-1264, 2009
• 78 Scanavacca M, "Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation" 114 : 876-885, 2006
• 79 Allison MA, "Sedentary behavior and adiposity-associated inflammation : the Multi-Ethnic Study of Atherosclerosis" 42 : 8-13, 2012
• 80 Patel D, "Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea : the impact of continuous positive airway pressure" 3 : 445-451, 2010
• 81 Li N, "Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model" 129 : 1276-1285, 2014
• 82 Mohlenkamp S, "Running : the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners" 29 : 1903-1910, 2008
• 83 Pandit SV, "Rotors and the dynamics of cardiac fibrillation" 112 : 849-862, 2013
• 84 Fast VG, "Role of wavefront curvature in propagation of cardiac impulse" 33 : 258-271, 1997
• 85 Chen PS, "Role of the autonomic nervous system in atrial fibrillation : pathophysiology and therapy" 114 : 1500-1515, 2014
• 86 Dublin S, "Risk of new-onset atrial fibrillation in relation to body mass index" 166 : 2322-2328, 2006
• 87 Andersen K, "Risk of arrhythmias in 52 755 longdistance cross-country skiers : a cohort study" 34 : 3624-3631, 2013
• 88 Roy D, "Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure" 358 : 2667-2677, 2008
• 89 Hocini M, "Reverse Remodeling of Sinus Node Function After Catheter Ablation of Atrial Fibrillation in Patients With Prolonged Sinus Pauses" 108 : 1172-1175, 2003
• 90 Gentlesk PJ, "Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation" 18 : 9-14, 2006
• 91 Gentlesk PJ, "Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation" 18 : 9-14, 2007
• 92 Verma A, "Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction" 112 : 627-635, 2005
• 93 Linz D, "Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea" 60 : 172-178, 2012
• 94 Pokushalov E, "Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension : early experience" 11 : 1131-1138, 2014
• 95 Aizer A, "Relation of vigorous exercise to risk of atrial fibrillation" 103 : 1572-1577, 2009
• 96 Psychari SN, "Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation" 95 : 764-767, 2005
• 97 Winkle RA, "Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes" 108 : 374-379, 2011
• 98 Zeng Y, "Recurrent Atrial Arrhythmia After Minimally Invasive Pulmonary Vein Isolation for Atrial Fibrillation" 90 : 510-515, 2010
• 99 Wakili R, "Recent advances in the molecular pathophysiology of atrial fibrillation" 121 : 2955-2968, 2011
• 100 Katritsis DG, "Rapid pulmonary vein isolation combined with autonomic ganglia modification : A randomized study" 8 : 672-678, 2011
• 101 Reddy VY, "Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force–Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation(TOCCASTAR)Study" 132 : 907-915, 2015
• 102 Carlsson Jö, "Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation : The Strategies of Treatment of Atrial Fibrillation(STAF)study" 41 : 1690-1696, 2003
• 103 Bassiouny M, "Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation" 9 : e003596-, 2016
• 104 Kusumoto F, "Radiofrequency catheter ablation of atrial fibrillation in older patients : outcomes and complications" 25 : 31-35, 2009
• 105 Furlanello F, "Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition" 19 : 457-462, 2008
• 106 Hakalahti A, "Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis" 17 : 370-378, 2015
• 107 MacDonald MR, "Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction : a randomised controlled trial" 97 : 740-747, 2011
• 108 MacDonald MR, "Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction : a randomised controlled trial" 97 : 740-747, 2011
• 109 Wazni OM, "Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation : A Randomized Trial" 293 : 2634-2640, 2005
• 110 Morillo CA, "Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation(RAAFT-2) : A Randomized Trial" 311 : 692-700, 2014
• 111 Cosedis Nielsen J, "Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation" 367 : 1587-1595, 2012
• 112 Chevalier P, "Quantitative study of nerves of the human left atrium" 2 : 518-522, 2005
• 113 Khan MN, "Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure" 359 : 1778-1785, 2008
• 114 Khan MN, "Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure" 359 : 1778-1785, 2008
• 115 Chen MS, "Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function" 43 : 1004-1009, 2004
• 116 Chen MS, "Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function" 43 : 1004-1009, 2004
• 117 Kato R, "Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation : lessons learned by use of magnetic resonance imaging" 107 : 2004-2010, 2003
• 118 Yu HT, "Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study" 10 : e004915-, 2017
• 119 Walters TE, "Progression of atrial remodeling in patients with high-burden atrial fibrillation : Implications for early ablative intervention" 13 : 331-339, 2016
• 120 de Vos CB, "Progression From Paroxysmal to Persistent Atrial Fibrillation : Clinical Correlates and Prognosis" 55 : 725-731, 2010
• 121 McElderry HT, "Proarrhythmic Aspects of Atrial Fibrillation Surgery : Mechanisms of Postoperative Macroreentrant Tachycardias" 117 : 155-162, 2008
• 122 Konrad T, "Primary Persistent Atrial Fibrillation : A Distinct Arrhythmia Subentity of an Ablation Population" 26 : 1289-1294, 2015
• 123 Healey JS, "Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers : a meta-analysis" 45 : 1832-1839, 2005
• 124 Kannel WB, "Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available" 82 : 2N-9N, 1998
• 125 Lin YJ, "Prevalence, characteristics, mapping, and catheter ablation of potential rotors in nonparoxysmal atrial fibrillation" 6 : 851-358, 2013
• 126 Joshi S, "Prevalence, Predictors, and Prognosis of Atrial Fibrillation Early After Pulmonary Vein Isolation : Findings from 3 Months of Continuous Automatic ECG Loop Recordings" 20 : 1089-1094, 2009
• 127 이소령, "Prevalence of Nonnonevalvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population" 대한심장학회 48 (48): 622-634, 2018
• 128 Pelliccia A, "Prevalence and clinical significance of left atrial remodeling in competitive athletes" 46 : 690-696, 2005
• 129 Lee S-H, "Predictors of Non-Pulmonary Vein Ectopic Beats Initiating Paroxysmal Atrial Fibrillation : Implication for Catheter Ablation" 46 : 1054-1059, 2005
• 130 Kochhäuser S, "Predictors for Progression of Atrial Fibrillation in Patients Awaiting Atrial Fibrillation Ablation" 32 : 1348-1354, 2016
• 131 Kang JH, "Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion" 23 : 1165-1170, 2012
• 132 Berruezo A, "Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation" 28 : 836-841, 2007
• 133 Letsas KP, "Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation : the potential role of inflammation" 11 : 158-163, 2009
• 134 Beyer E, "Point : Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation : Early multicenter results" 137 : 521-526, 2009
• 135 Pelliccia A, "Physiologic left ventricular cavity dilatation in elite athletes" 130 : 23-31, 1999
• 136 Hummel J, "Phased RF ablation in persistent atrial fibrillation" 11 : 202-209, 2014
• 137 Wong CX, "Pericardial fat is associated with atrial fibrillation severity and ablation outcome" 57 : 1745-1751, 2011
• 138 Hindricks G, "Perception of atrial fibrillation before and after radiofrequency catheter ablation : relevance of asymptomatic arrhythmia recurrence" 112 : 307-313, 2005
• 139 Bunch TJ, "Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation" 22 : 839-845, 2011
• 140 Schotten U, "Pathophysiological Mechanisms of Atrial Fibrillation : A Translational Appraisal" 91 : 265-325, 2011
• 141 Nakagawa H, "Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation" 6 : S26-S34, 2009
• 142 Hoogsteen J, "Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up" 6 : 222-228, 2004
• 143 Pedrote A, "Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation : an observational study through a subcutaneous leadless cardiac monitor" 24 : 1075-1082, 2013
• 144 Nattel S, "Paroxysmal Atrial Fibrillation and Pulmonary Veins : Relationships Between Clinical Forms and Automatic Versus Re-entrant Mechanisms" 29 : 1147-1149, 2013
• 145 Natale A, "Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter" 64 : 647-656, 2014
• 146 Fox CS, "Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring" 291 : 2851-2855, 2004
• 147 Honjo H, "Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine" 107 : 1937-1943, 2003
• 148 Chen YW, "Pacing or Ablation: Which Is Better for Paroxysmal Atrial Fibrillation‐Related Tachycardia‐Bradycardia Syndrome" 37 : 403-411, 2014
• 149 Patel D, "Outcomes and complications of catheter ablation for atrial fibrillation in females" 7 : 167-172, 2010
• 150 Wang L, "Optical mapping of sarcoplasmic reticulum Ca2+in the intact heart : ryanodine receptor refractoriness during alternans and fibrillation" 114 : 1410-1421, 2014
• 151 Mines GR, "On circulating excitations in heart muscle and their possible relation to tachycardia and fibrillation" 8 : 43-52, 1914
• 152 Lewis T, "Oliver-Sharpey Lectures on the Nature of Flutter and Fibrillation of the Auricle" 1 : 551-555, 1921
• 153 Gami AS, "Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation" 49 : 565-571, 2007
• 154 Kanagala R, "Obstructive sleep apnea and the recurrence of atrial fibrillation" 107 : 2589-2594, 2003
• 155 Valderrábano M, "Obstacle-induced transition from ventricular fibrillation to tachycardia in isolated swine right ventricles : Insights into the transition dynamics and implications for the critical mass" 36 : 2000-2008, 2000
• 156 Miller JD, "Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation" 66 : 2899-2906, 2015
• 157 Miller JD, "Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation" 66 : 2899-2906, 2015
• 158 Abed HS, "Obesity results in progressive atrial structural and electrical remodeling : implications for atrial fibrillation" 10 : 90-100, 2013
• 159 Wong CX, "Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation : A Meta-Analysis of 626, 603 Individuals in 51 Studies" 1 : 139-152, 2015
• 160 Everett BM, "Novel genetic markers improve measures of atrial fibrillation risk prediction" 34 : 2243-2251, 2013
• 161 Lubitz SA, "Novel Genetic Markers Associate With Atrial Fibrillation Risk in Europeans and Japanese" 63 : 1200-1210, 2014
• 162 Jongbloed MRM, "Noninvasive visualization of the cardiac venous system using multislice computed tomography" 45 : 749-753, 2005
• 163 Cuculich PS, "Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns" 122 : 1364-1372, 2010
• 164 Nattel S, "New ideas about atrial fibrillation 50 years on" 415 : 219-, 2002
• 165 Hou Y, "Neuromodulation for cardiac arrhythmia" 13 : 584-592, 2016
• 166 Linz D, "Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation" 8 : 1436-1443, 2011
• 167 Krul SPJ, "Navigating the minimaze : Systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation" 166 : 132-140, 2013
• 168 Pashakhanloo F, "Myofiber Architecture of the Human Atria as Revealed by Submillimeter Diffusion Tensor Imaging" 9 : e004133-, 2016
• 169 Wei SK, "Muscarinic modulation of the sodium-calcium exchanger in heart failure" 115 : 1225-1233, 2007
• 170 Jalife J, "Mother rotors and fibrillatory conduction : a mechanism of atrial fibrillation" 54 : 204-216, 2002
• 171 Pappone C, "Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation : Outcomes from a controlled nonrandomized long-term study" 42 : 185-197, 2003
• 172 Ghanbari H, "Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation" 11 : 1503-1511, 2014
• 173 Miyasaka Y, "Mortality Trends in Patients Diagnosed With First Atrial Fibrillation : A 21-Year Community-Based Study" 49 : 986-992, 2007
• 174 Pauza DH, "Morphology of the Intrinsic Cardiac Nervous System in the Dog : A Whole-Mount Study Employing Histochemical Staining with Acetylcholinesterase" 172 : 297-320, 2002
• 175 Edgerton JR, "Minimally invasive surgical ablation of atrial fibrillation : Sixmonth results" 138 : 109-114, 2009
• 176 Edgerton JR, "Minimally Invasive Pulmonary Vein Isolation and Partial Autonomic Denervation for Surgical Treatment of Atrial Fibrillation" 86 : 35-39, 2008
• 177 Spach MS, "Microfibrosis produces electrical load variations due to loss of side-to-side cell connections : a major mechanism of structural heart disease arrhythmias" 20 : 397-413, 1997
• 178 Tang RB, "Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation" 73 : 438-443, 2009
• 179 Huxley RR, "Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation" 108 : 56-62, 2011
• 180 Ellinor PT, "Meta-analysis identifies six new susceptibility loci for atrial fibrillation" 44 : 670-, 2012
• 181 Levin MD, "Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers" 119 : 3420-3436, 2009
• 182 Jalife J, "Mechanisms of persistent atrial fibrillation" 29 : 20-27, 2014
• 183 Jalife J, "Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both" 9 : S2-S12, 1998
• 184 Kneller J, "Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model" 96 : e35-e47, 2005
• 185 Magnano AR, "Mechanisms of Atrial Tachyarrhythmias Following Surgical Atrial Fibrillation Ablation" 17 : 366-373, 2006
• 186 Nattel S, "Mechanisms of Atrial Fibrillation : Lessons From Animal Models" 48 : 9-28, 2005
• 187 Anné W, "Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation" 67 : 655-666, 2005
• 188 Mlcochová H, "Magnetic Resonance Angiography of Pulmonary Veins : Implications for Catheter Ablation of Atrial Fibrillation" 28 : 1073-1080, 2005
• 189 Matiello M, "Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients" 12 : 1084-1089, 2010
• 190 Chiang DY, "Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release" 7 : 1214-1222, 2014
• 191 Gay-Jordi G, "Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model" 8 : e55427-, 2013
• 192 Bunch TJ, "Long‐Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians" 33 : 146-152, 2009
• 193 Ouyang F, "Long-term results of catheter ablation in paroxysmal atrial fibrillation : lessons from a 5-year follow-up" 122 : 2368-2377, 2010
• 194 Arya A, "Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients" 12 : 173-180, 2010
• 195 Ganesan AN, "Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis" 2 : e004549-, 2013
• 196 Perez FJ, "Long-term outcomes after catheter ablation of cavotricuspid isthmus dependent atrial flutter : a meta-analysis" 2 : 393-401, 2009
• 197 Wokhlu A, "Long-term outcome of atrial fibrillation ablation : impact and predictors of very late recurrence" 21 : 1071-1078, 2010
• 198 Shah AN, "Long-term outcome following successful pulmonary vein isolation : pattern and prediction of very late recurrence" 19 : 661-667, 2008
• 199 Filgueiras-Rama D, "Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium" 5 : 1160-1167, 2012
• 200 Wokhlu A, "Long-Term Q uality of Life After Ablation of Atrial Fibrillation : The Impact of Recurrence, Symptom Relief, and Placebo Effect" 55 : 2308-2316, 2010
• 201 Roh S-Y, "Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy" 27 : 788-795, 2016
• 202 Wokhlu A, "Long-Term Outcome of Atrial Fibrillation Ablation : Impact and Predictors of Very Late Recurrence" 21 : 1071-1078, 2010
• 203 Po SS, "Localization of Left Atrial Ganglionated Plexi in Patients with Atrial Fibrillation" 20 : 1186-1189, 2009
• 204 Lockwood D, "Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: Techniques for assessing conduction block across surgical lesions" 6 : S50-S63, 2009
• 205 Lloyd-Jones DM, "Lifetime risk for development of atrial fibrillation : the Framingham Heart Study" 110 : 1042-1046, 2004
• 206 Lloyd-Jones DM, "Lifetime risk for development of atrial fibrillation : the Framingham Heart Study" 110 : 1042-1046, 2004
• 207 Rensma PL, "Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs" 62 : 395-410, 1988
• 208 Voigt N, "Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation" 3 : 472-480, 2010
• 209 Deshmukh A, "Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence" 8 : 32-41, 2015
• 210 Chevalier P, "Left atrial radiofrequency ablation during mitral valve surgery : a prospective randomized multicentre study(SAFIR)" 102 : 769-775, 2009
• 211 Park HC, "Left atrial functional reservoir : predictive value for outcome of catheter ablation in paroxysmal atrial fibrillation" 30 : 1423-1434, 2014
• 212 Ho SY, "Left atrial anatomy revisited" 5 : 220-228, 2012
• 213 Doukas G, "Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation : A Randomized Controlled Trial" 294 : 2323-2329, 2005
• 214 Henn MC, "Late outcomes after the Cox maze IV procedure for atrial fibrillation" 150 : 1168-1178.e2, 2015
• 215 Choi EK, "Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success" 4 : e002046-, 2015
• 216 Podduturi V, "Isolated Atrial Amyloidosis and the Importance of Molecular Classification" 26 : 387-389, 2013
• 217 Abdulla J, "Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis" 11 : 1156-1159, 2009
• 218 Richter B, "Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor" 27 : 2553-2559, 2006
• 219 Choi EK, "Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs" 121 : 2615-2623, 2010
• 220 Kalifa J, "Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation" 108 : 668-671, 2003
• 221 Haissaguerre M, "Intermittent drivers anchoring to structural heterogeneities as a major pathophysiological mechanism of human persistent atrial fibrillation" 594 : 2387-2398, 2016
• 222 Zhao J, "Integration of High-Resolution Optical Mapping and 3-Dimensional Micro-Computed Tomographic Imaging to Resolve the Structural Basis of Atrial Conduction in the Human Heart" 8 : 1514-1517, 2015
• 223 Sinner MF, "Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation" 130 : 1225-1235, 2014
• 224 Conen D, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women" 119 : 2146-2152, 2009
• 225 Reynolds MR, "Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation : The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle(FRACTAL)study" 152 : 1097-1103, 2006
• 226 Engelmann MD, "Inflammation in the genesis and perpetuation of atrial fibrillation" 26 : 2083-2092, 2005
• 227 Benjamin EJ, "Independent risk factors for atrial fibrillation in a populationbased cohort : The framingham heart study" 271 : 840-844, 1994
• 228 Benjamin EJ, "Independent risk factors for atrial fibrillation in a population-based cohort" 271 : 840-844, 1994
• 229 Kraiczi H, "Increased vasoconstrictor sensitivity in obstructive sleep apnea" 89 : 493-498, 2000
• 230 Andrade JG, "Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation : insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation(STOP AF)Trial" 7 : 69-75, 2014
• 231 Andrade JG, "Incidence and Significance of Early Recurrences Associated with Different Ablation Strategies for AF : A STAR-AF Substudy" 23 : 1295-1301, 2012
• 232 Mainigi SK, "Incidence and Predictors of Very Late Recurrence of Atrial Fibrillation After Ablation" 18 : 69-74, 2007
• 233 Caballero R, "In Humans, Chronic Atrial Fibrillation Decreases the Transient Outward Current and Ultrarapid Component of the Delayed Rectifier Current Differentially on Each Atria and Increases the Slow Component of the Delayed Rectifier Current in Both" 55 : 2346-2354, 2010
• 234 Louagie Y, "Improved Patient Survival With Concomitant Cox Maze III Procedure Compared With Heart Surgery Alone" 87 : 440-446, 2009
• 235 Dong LW, "Impairment of the ryanodinesensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis" 16 : 33-39, 2001
• 236 Weiss C, "Impact of the distribution and structure of myocardium in the pulmonary veins for radiofrequency ablation of atrial fibrillation" 25 : 1352-1356, 2002
• 237 Holmqvist F, "Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)" 169 : 647-654 e2, 2015
• 238 Lin KJ, "Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation : systematic review and metaanalysis" 39 : 211-223, 2014
• 239 Mohanty S, "Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation" 59 : 1295-1301, 2012
• 240 Ejima K, "Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation" 164 : 88-93, 2013
• 241 Tayebjee MH, "Impact of angiotensin-converting enzymeinhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation" 12 : 1537-1542, 2010
• 242 Santoro F, "Impact of Uncontrolled Hypertension on Atrial Fibrillation Ablation Outcome" 1 : 164-173, 2015
• 243 Yoo JS, "Impact of Concomitant Surgical Atrial Fibrillation Ablation in Patients Undergoing Aortic Valve Replacement" 78 : 1364-1371, 2014
• 244 Olivotto I, "Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy" 104 : 2517-2524, 2001
• 245 Qiao Y, "Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation" 4 : 2015
• 246 Kottkamp H, "Human atrial fibrillation substrate : towards a specific fibrotic atrial cardiomyopathy" 34 : 2731-2738, 2013
• 247 Grubman E, "Histopathologic Effects of Radiofrequency Catheter Ablation in Previously Infarcted Human Myocardium" 10 : 336-342, 1999
• 248 Chen YC, "Heterogeneous Expression of Potassium Currents and Pacemaker Currents Potentially Regulates Arrhythmogenesis of Pulmonary Vein Cardiomyocytes" 20 : 1039-1045, 2009
• 249 Holmqvist F, "Heart rate is associated with progression of atrial fibrillation, independent of rhythm" 101 : 894-899, 2015
• 250 Calkins H, "HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society" 4 : 816-861, 2007
• 251 Camm AJ, "Guidelines for the management of atrial fibrillation : the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)" 12 : 1360-1420, 2010
• 252 Camm AJ, "Guidelines for the management of atrial fibrillation : the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)" 12 : 1360-1420, 2010
• 253 Armour JA, "Gross and microscopic anatomy of the human intrinsic cardiac nervous system" 247 : 289-298, 1997
• 254 Zhou J, "Gradients of Atrial Refractoriness and Inducibility of Atrial Fibrillation due to Stimulation of Ganglionated Plexi" 18 : 83-90, 2007
• 255 Christophersen IE, "Genetics of atrial fibrillation : from families to genomes" 61 : 61-, 2015
• 256 Lubitz SA, "Genetic Risk Prediction of Atrial Fibrillation" 135 : 1311-1320, 2017
• 257 Choi EK, "Ganglionated plexi as neuromodulation targets for atrial fibrillation" 28 : 1485-1491, 2017
• 258 Hou Y, "Ganglionated Plexi Modulate Extrinsic Cardiac Autonomic Nerve Input : Effects on Sinus Rate, Atrioventricular Conduction, Refractoriness, and Inducibility of Atrial Fibrillation" 50 : 61-68, 2007
• 259 Driessen AHG, "Ganglion Plexus Ablation in Advanced Atrial Fibrillation : The AFACT Study" 68 : 1155-1165, 2016
• 260 Driessen AHG, "Ganglion Plexus Ablation in Advanced Atrial Fibrillation" 68 : 1155-1165, 2016
• 261 Boer RA, "Galectin-3 : a novel mediator of heart failure development and progression" 11 : 811-817, 2009
• 262 Bunch TJ, "Five‐Year Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction" 26 : 363-370, 2015
• 263 Scherr D, "Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint" 8 : 18-24, 2015
• 264 Kottkamp H, "Fibrotic Atrial Cardiomyopathy : A Specific Disease/Syndrome Supplying Substrates for Atrial Fibrillation, Atrial Tachycardia, Sinus Node Disease, AV Node Disease, and Thromboembolic Complications" 23 : 797-799, 2012
• 265 de Oliveira ÍM, "Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections : do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study" 22 : 65-69, 2013
• 266 Wilber DJ, "Fibroblasts, focal triggers, and persistent atrial fibrillation: is there a connection" 5 : 249-251, 2012
• 267 Lemery R, "Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation" 3 : 387-396, 2006
• 268 Arnar DO, "Familial aggregation of atrial fibrillation in Iceland" 27 : 708-712, 2006
• 269 Po SS, "Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions" 3 : 201-208, 2006
• 270 Go AS, "Executive summary : heart disease and stroke statistics--2014 update : a report from the American Heart Association" 129 : 399-410, 2014
• 271 Perez-Lugones A, "Evidence of Specialized Conduction Cells in Human Pulmonary Veins of Patients with Atrial Fibrillation" 14 : 803-809, 2003
• 272 Mahnkopf C, "Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI : Implications for disease progression and response to catheter ablation" 7 : 1475-1481, 2010
• 273 Force ESCT, "European Heart Rhythm Association(EHRA)/European Association of Cardiovascular Prevention and Rehabilitation(EACPR)position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society(HRS)and Asia Pacific Heart Rhythm Society(APHRS)" 19 : 190-225, 2017
• 274 Kim MH, "Estimation of total incremental health care costs in patients with atrial fibrillation in the United States" 4 : 313-320, 2011
• 275 Colilla S, "Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population" 112 : 1142-1147, 2013
• 276 Kannel WB, "Epidemiologic features of chronic atrial fibrillation : the Framingham study" 306 : 1018-1022, 1982
• 277 Voigt N, "Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation" 125 : 2059-2070, 2012
• 278 Mont L, "Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter" 11 : 11-17, 2009
• 279 Jongbloed MR, "Embryonic Conduction Tissue" 15 : 349-355, 2004
• 280 Driessen AHG, "Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation" 69 : 1753-1754, 2017
• 281 Mahajan R, "Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity" 66 : 1-11, 2015
• 282 Mahajan R, "Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity" 66 : 1-11, 2015
• 283 Han S, "Electrophysiological characteristics of the Marshall bundle in humans" 7 : 786-793, 2010
• 284 Munger TM, "Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation" 60 : 851-860, 2012
• 285 Kumagai K, "Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter" 43 : 2281-2289, 2004
• 286 Allessie M, "Electrical, contractile and structural remodeling during atrial fibrillation" 54 : 230-246, 2002
• 287 Hocini M, "Electrical conduction in canine pulmonary veins : electrophysiological and anatomic correlation" 105 : 2442-2448, 2002
• 288 Machino-Ohtsuka T, "Efficacy, Safety, and Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction" 62 : 1857-1865, 2013
• 289 Koopman P, "Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation" 13 : 1386-1393, 2011
• 290 Koopman P, "Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation" 13 : 1386-1393, 2011
• 291 Calvo N, "Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes" 12 : 30-36, 2010
• 292 Calvo N, "Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes" 12 : 30-36, 2010
• 293 Li L, "Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment : a meta-analysis of observational studies" 16 : 1309-1314, 2014
• 294 Gi-Hyeon Seo, "Efficacy and Safety Outcomes of Catheter Ablation of Non-valvular Atrial Fibrillation in Korean Practice: Analysis of Nationwide Claims Data" 대한부정맥학회 19 (19): 14-21, 2018
• 295 Leong-Sit P, "Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of AgeClinical Perspective" 3 : 452-457, 2010
• 296 Chiou CW, "Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes" 95 : 2573-2584, 1997
• 297 Tsai W-C, "Effects of renal sympathetic denervation on the stellate ganglion and brain stem in dogs" 14 : 255-262, 2017
• 298 Chen YJ, "Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins : implication in initiation of atrial fibrillation" 104 : 2849-2854, 2001
• 299 Bauer A, "Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function" 3 : 1428-1435, 2006
• 300 Wongcharoen W, "Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity" 70 : 497-508, 2006
• 301 Filho CACA, "Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease" 112 : I-20-I-25, 2005
• 302 Neilan TG, "Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation" 2 : e000421-, 2013
• 303 Linz D, "Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea" 62 : 767-774, 2013
• 304 Fletcher EC, "Effect of episodic hypoxia on sympathetic activity and blood pressure" 119 : 189-197, 2000
• 305 Alonso A, "Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial" 170 : 770-777.e5, 2015
• 306 Liang JJ, "Early recurrence of atrial arrhythmias following pulmonary vein antral isolation: Timing and frequency of early recurrences predicts long-term ablation success" 12 : 2461-2468, 2015
• 307 Özgen N, "Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2channels to membrane sites" 75 : 758-769, 2007
• 308 Goette A, "EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies : definition, characterization, and clinical implication" 18 : 1455-1490, 2016
• 309 Jalife J, "Déjà vu in the theories of atrial fibrillation dynamics" 89 : 766-775, 2011
• 310 van der Does LJME, "Dynamics of Endo- and Epicardial Focal Fibrillation Waves at the Right Atrium in a Patient With Advanced Atrial Remodelling" 32 : 1260.e19-1260.e21, 2016
• 311 Greiser M, "Dynamic remodeling of intracellular Ca2+ signaling during atrial fibrillation" 58 : 134-142, 2013
• 312 Haissaguerre M, "Driver domains in persistent atrial fibrillation" 130 : 530-538, 2014
• 313 Martins RP, "Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation" 129 : 1472-1482, 2014
• 314 Kim J-S, "Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation?" 181 : 277-283, 2015
• 315 Opolski PLAMKAEKAAPAPBAJKAPSARPAG, "Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up" 2014
• 316 Jais P, "Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation" 106 : 2479-2485, 2002
• 317 Weerasooriya R, "Dissociated Pulmonary Vein Arrhythmia" 14 : 1173-1179, 2003
• 318 Verma A, "Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation(discern af) : A prospective, multicenter study" 173 : 149-156, 2013
• 319 de Groot N, "Direct Proof of Endo-Epicardial Asynchrony of the Atrial Wall During Atrial Fibrillation in Humans" 9 : 2016
• 320 Iwasaki YK, "Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea" 9 : 1409-1416 e1, 2012
• 321 Fenelon G, "Delayed Effects of Radiofrequency Energy : Mechanisms and Clinical Implications" 19 : 484-489, 1996
• 322 Kuck KH, "Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation" 374 : 2235-2245, 2016
• 323 Packer DL, "Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial FibrillationFirst Results of the North American Arctic Front(STOP AF)Pivotal Trial" 61 : 1713-1723, 2013
• 324 Naruse Y, "Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation : clinical impact of continuous positive airway pressure therapy" 10 : 331-337, 2013
• 325 Budera P, "Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study" 33 : 2644-2652, 2012
• 326 Wu L, "Comparison of Radiofrequency Catheter Ablation Between Asymptomatic and Symptomatic Persistent Atrial Fibrillation : A Propensity Score Matched Analysis" 27 : 531-535, 2016
• 327 Wilber DJ, "Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation : A Randomized Controlled Trial" 303 : 333-340, 2010
• 328 Shoemaker MB, "Common genetic variants and response to atrial fibrillation ablation" 8 : 296-302, 2015
• 329 Oral H, "Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation" 40 : 100-104, 2002
• 330 Chrispin J, "Clinical predictors of cardiac magnetic resonance late gadolinium enhancement in patients with atrial fibrillation" 19 : 371-377, 2017
• 331 Forleo GB, "Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation : The IRON-AF(Italian Registry on NavX Atrial Fibrillation Ablation Procedures)study" 168 : 3968-3970, 2013
• 332 Kim SK, "Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion" 11 : 1632-1638, 2009
• 333 Allessie MA, "Circus movement in rabbit atrial muscle as a mechanism of trachycardia" 33 : 54-62, 1973
• 334 Allessie MA, "Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle" 41 : 9-18, 1977
• 335 Eitel C, "Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block : The paceand-ablate approach" 7 : 157-164, 2010
• 336 "Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation" 8 : 2006
• 337 Nattel S, "Changes in the atrial transcriptome and atrial fibrillation : susceptibility, persistence, causes, and consequences" 8 : 5-7, 2015
• 338 Choi JI, "Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation" 72 : 2051-2057, 2008
• 339 Ehrlich JR, "Cellular electrophysiology of canine pulmonary vein cardiomyocytes : action potential and ionic current properties" 551 : 801-813, 2003
• 340 Voigt N, "Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation" 129 : 145-156, 2014
• 341 Heijman J, "Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression" 114 : 1483-1499, 2014
• 342 Sotomi Y, "Cause of Very Late Recurrence of Atrial Fibrillation or Flutter After Catheter Ablation for Atrial Fibrillation" 111 : 552-556, 2013
• 343 Mont L, "Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)" eht457-, 2013
• 344 Jais P, "Catheter ablation versus antiarrhythmic drugs for atrial fibrillation : the A4 study" 118 : 2498-2505, 2008
• 345 Stabile G, "Catheter ablation treatment in patients with drug-refractory atrial fibrillation : a prospective, multi-centre, randomized, controlled study(Catheter Ablation For The Cure Of Atrial Fibrillation Study)" 27 : 216-221, 2006
• 346 Lutomsky BA, "Catheter ablation of paroxysmal atrial fibrillation improves cardiac function : a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging" 10 : 593-599, 2008
• 347 Chun KRJ, "Catheter ablation of atrial fibrillation in the young : insights from the German Ablation Registry" 102 : 459-468, 2013
• 348 Providencia R, "Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy : a systematic review and metaanalysis" 102 : 1533-1543, 2016
• 349 Santangeli P, "Catheter Ablation of Atrial Fibrillation in Octogenarians : Safety and Outcomes" 23 : 687-693, 2012
• 350 Chen SA, "Catheter Ablation of Atrial Fibrillation Originating from the Non-Pulmonary Vein Foci" 16 : 229-232, 2005
• 351 Mohanty S, "Catheter Ablation of Asymptomatic Longstanding Persistent Atrial Fibrillation : Impact on Quality of Life, Exercise Performance, Arrhythmia Perception, and Arrhythmia‐Free Survival" 25 : 1057-1064, 2014
• 352 Weerasooriya R, "Catheter Ablation for Atrial Fibrillation: Are Results Maintained at 5 Years of Follow-Up" 57 : 160-166, 2011
• 353 Marrouche NF, "Catheter Ablation for Atrial Fibrillation with Heart Failure" 378 : 417-427, 2018
• 354 Marrouche NF, "Catheter Ablation for Atrial Fibrillation with Heart Failure" 378 : 417-427, 2018
• 355 Halabi SA, "Catheter Ablation for Atrial Fibrillation in Heart Failure Patients : A Meta-Analysis of Randomized Controlled Trials" 1 : 200-, 2015
• 356 Li-Fern H, "Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure" 11 : 2004
• 357 Jaïs P, "Catheter Ablation Versus Antiarrhythmic Drugs for Atrial FibrillationCLINICAL PERSPECTIVE : The A4 Study" 118 : 2498-2505, 2008
• 358 Qureshi WT, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation : Results From the Henry Ford Exercise Testing(FIT)Project" 131 : 1827-1834, 2015
• 359 Benito B, "Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training" 123 : 13-22, 2011
• 360 Chung MK, "C-reactive protein elevation in patients with atrial arrhythmias : inflammatory mechanisms and persistence of atrial fibrillation" 104 : 2886-2891, 2001
• 361 Kottkamp H, "Box Isolation of Fibrotic Areas(BIFA) : A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation" 27 : 22-30, 2015
• 362 Jongnarangsin K, "Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation" 19 : 668-672, 2008
• 363 Thomas MC, "Blood pressure control and risk of incident atrial fibrillation" 21 : 1111-1116, 2008
• 364 Tremblay-Gravel M, "Blood Pressure and Atrial Fibrillation : A Combined AF-CHF and AFFIRM Analysis" 26 : 509-514, 2015
• 365 Smorodinova N, "Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences" 10 : e0129124-, 2015
• 366 Lindsay MM, "Biochemical evidence of myocardial fibrosis in veteran endurance athletes" 41 : 447-452, 2007
• 367 Lin Y-J, "Benefits of Atrial Substrate Modification Guided by Electrogram Similarity and Phase Mapping Techniques to Eliminate Rotors and Focal Sources Versus Conventional Defragmentation in Persistent Atrial Fibrillation" 2 : 667-678, 2016
• 368 Nademanee K, "Benefits and risks of catheter ablation in elderly patients with atrial fibrillation" 12 : 44-51, 2015
• 369 Chen J, "Back to the Future : The Role of the Autonomic Nervous System in Atrial Fibrillation" 29 : 413-421, 2006
• 370 Scherlag BJ, "Autonomically Induced Conversion of Pulmonary Vein Focal Firing Into Atrial Fibrillation" 45 : 1878-1886, 2005
• 371 Bettoni M, "Autonomic tone variations before the onset of paroxysmal atrial fibrillation" 105 : 2753-2759, 2002
• 372 Tan AY, "Autonomic Innervation and Segmental Muscular Disconnections at the Human Pulmonary Vein-Atrial Junction : Implications for Catheter Ablation of Atrial-Pulmonary Vein Junction" 48 : 132-143, 2006
• 373 Katritsis DG, "Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation : A Randomized Clinical Trial" 62 : 2318-2325, 2013
• 374 Jalife J, "Atrial remodeling, fibrosis, and atrial fibrillation" 25 : 475-484, 2015
• 375 Dimitri H, "Atrial remodeling in obstructive sleep apnea : implications for atrial fibrillation" 9 : 321-327, 2012
• 376 Nattel S, "Atrial remodeling and atrial fibrillation : mechanisms and implications" 1 : 62-73, 2008
• 377 Iwasaki YK, "Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model" 64 : 2013-2023, 2014
• 378 Jayachandran JV, "Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation" 101 : 1185-1191, 2000
• 379 Lubitz SA, "Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community" 2 : e000126-, 2013
• 380 Hsu LF, "Atrial fibrillation originating from persistent left superior vena cava" 109 : 828-832, 2004
• 381 Haemers P, "Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria" 38 : 53-61, 2017
• 382 Hove-Madsen L, "Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes" 110 : 1358-1363, 2004
• 383 He X, "Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7" 108 : 164-175, 2011
• 384 Sorokin AV, "Atrial fibrillation in endurance-trained athletes" 45 : 185-188, 2011
• 385 Swanson DR, "Atrial fibrillation in athletes : implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism" 66 : 1085-1092, 2006
• 386 Corradi D, "Atrial fibrillation from the pathologist’s perspective" 23 : 71-84, 2014
• 387 Hansen BJ, "Atrial fibrillation driven by microanatomic intramural re-entry revealed by simultaneous subepicardial and sub-endocardial optical mapping in explanted human hearts" 36 : 2390-2401, 2015
• 388 Wijffels MC, "Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats" 92 : 1954-1968, 1995
• 389 Lu Z, "Atrial fibrillation begets atrial fibrillation : autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing" 1 : 184-192, 2008
• 390 Korantzopoulos P, "Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress" 9 : RA225-RA229, 2003
• 391 Jacobs V, "Atrial fibrillation and dementia" 25 : 44-51, 2015
• 392 Stevenson IH, "Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia : implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea" 7 : 1263-1270, 2010
• 393 Jin Hwang H, "Atrial electroanatomical remodeling as a determinant of different outcomes between two current ablation strategies: circumferential pulmonary vein isolation vs pulmonary vein isolation" 33 : E69-E74, 2010
• 394 Kistler PM, "Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure : implications for development of atrial fibrillation" 27 : 3045-3056, 2006
• 395 Goette A, "Atrial amyloidosis and atrial fibrillation: a gender-dependent “arrhythmogenic substrate”?" 25 : 1185-1186, 2004
• 396 Rocken C, "Atrial amyloidosis : an arrhythmogenic substrate for persistent atrial fibrillation" 106 : 2091-2097, 2002
• 397 Van Wagoner DR, "Atrial L-type Ca2+ currents and human atrial fibrillation" 85 : 428-436, 1999
• 398 Akoum N, "Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker Implant" 23 : 44-50, 2011
• 399 Chen LY, "Atrial Fibrillation and Its Association With Sudden Cardiac Death" 78 : 2588-2593, 2014
• 400 Hucker WJ, "Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future" 32 : 1300-1305, 2016
• 401 Boersma LVA, "Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment(FAST)Clinical Perspective : A 2-Center Randomized Clinical Trial" 125 : 23-30, 2012
• 402 Wazni OM, "Atrial Arrhythmias After Surgical Maze" 48 : 1405-1409, 2006
• 403 Rienstra M, "Asymptomatic persistent atrial fibrillation and outcome : Results of the RACE study" 11 : 939-945, 2014
• 404 Boriani G, "Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry" 128 : 509-518.e2, 2015
• 405 Chao TF, "Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation" 75 : 2326-2332, 2011
• 406 Kwon Y, "Association of sleep characteristics with atrial fibrillation : the Multi-Ethnic Study of Atherosclerosis" 70 : 873-879, 2015
• 407 Marrouche NF, "Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation : the DECAAF study" 311 : 498-506, 2014
• 408 Lubitz SA, "Association between familial atrial fibrillation and risk of new-onset atrial fibrillation" 304 : 2263-2269, 2010
• 409 Cherniavsky A, "Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders" 18 : 727-731, 2014
• 410 Arora R, "Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping" 107 : 1816-1821, 2003
• 411 Christ T, "Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation" 111 : 11193-11198, 2014
• 412 Ettinger PO, "Arrhythmias and the"Holiday Heart" : alcoholassociated cardiac rhythm disorders" 95 : 555-562, 1978
• 413 Miller PS, "Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated" 36 : 360-366, 2005
• 414 Allan V, "Are cardiovascular risk factors also associated with the incidence of atrial fibrillation" 117 : 837-850, 2017
• 415 Eijsvogels TM, "Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise" 96 : 99-125, 2016
• 416 Wang K, "Architecture of atrial musculature in humans" 73 : 559-565, 1995
• 417 Verma A, "Approaches to Catheter Ablation for Persistent Atrial Fibrillation" 372 : 1812-1822, 2015
• 418 Ho SY, "Anatomy of the left atrium for interventional electrophysiologists" 33 : 620-627, 2010
• 419 Ho SY, "Anatomy of the left atrium : implications for radiofrequency ablation of atrial fibrillation" 10 : 1525-1533, 1999
• 420 Katritsis D, "Anatomic Approach for Ganglionic Plexi Ablation in Patients With Paroxysmal Atrial Fibrillation" 102 : 330-334, 2008
• 421 Hsieh MH, "Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins" 100 : 2237-2243, 1999
• 422 Pathak RK, "Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation : the ARREST-AF cohort study" 64 : 2222-2231, 2014
• 423 Cochet H, "Age, Atrial Fibrillation, and Structural Heart Disease Are the Main Determinants of Left Atrial Fibrosis Detected by Delayed-Enhanced Magnetic Resonance Imaging in a General Cardiology Population" 26 : 484-492, 2015
• 424 Malmo V, "Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term : A Randomized Trial" 133 : 466-473, 2016
• 425 Basso C, "Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy" 14 : 37-41, 2005
• 426 Macle L, "Adenosineguided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation : an international, multicentre, randomised superiority trial" 386 : 672-679, 2015
• 427 Atienza F, "Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans : evidence for a reentrant mechanism" 114 : 2434-2442, 2006
• 428 Huxley RR, "Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors : the Atherosclerosis Risk in Communities(ARIC)study" 123 : 1501-1508, 2011
• 429 Choi AD, "Ablation vs Medical Therapy in the Setting of Symptomatic Atrial Fibrillation and Left Ventricular Dysfunction" 16 : 10-14, 2010
• 430 Metzner I, "Ablation of atrial fibrillation in patients ≥75 years : long-term clinical outcome and safety" 18 : 543-549, 2016
• 431 Narayan SM, "Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone : Extended Follow-Up of the CONFIRM Trial(Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)" 63 : 1761-1768, 2014
• 432 Kearney K, "A systematic review of surgical ablation versus catheter ablation for atrial fibrillation" 3 : 15-29, 2014
• 433 Gudbjartsson DF, "A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke" 41 : 876-, 2009
• 434 Blomström-Lundqvist C, "A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery : the SWEDish Multicentre Atrial Fibrillation study(SWEDMAF)" 28 : 2902-2908, 2007
• 435 Hunter RJ, "A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure(the CAMTAF trial)" 7 : 31-38, 2014
• 436 Pokushalov E, "A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension" 60 : 1163-1170, 2012
• 437 Moe GK, "A computer model of atrial fibrillation" 67 : 200-220, 1964
• 438 Wyse DG, "A comparison of rate control and rhythm control in patients with atrial fibrillation" 347 : 1825-1833, 2002
• 439 Dagres N, "A Systematic Review and Meta-Analysis" 17 : 964-970, 2011
• 440 Jones DG, "A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure" 61 : 1894-1903, 2013
• 441 Pappone C, "A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation" 48 : 2340-2347, 2006
• 442 Hunter RJ, "A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure(The CAMTAF Trial)" 7 : 31-38, 2014
• 443 Pokushalov E, "A Randomized Comparison of Pulmonary Vein Isolation With Versus Without Concomitant Renal Artery Denervation in Patients With Refractory Symptomatic Atrial Fibrillation and Resistant Hypertension" 60 : 1163-1170, 2012
• 444 Edgerton JR, "A New Epicardial Lesion Set for Minimal Access Left Atrial Maze : The Dallas Lesion Set" 88 : 1655-1657, 2009
• 445 Van Gelder IC, "A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation" 347 : 1834-1840, 2002
• 446 Potpara TS, "A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation : Implications of Arrhythmia Progression on Prognosis : The Belgrade Atrial Fibrillation Study" 141 : 339-347, 2012
• 447 January CT, "2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society" 64 : e1-e76, 2014
• 448 January CT, "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society" 64 : e1-e76, 2014